SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000903423-17-000691
Filing Date
2017-11-16
Accepted
2017-11-16 17:03:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 glaxo-spero13d_1116.htm SC 13D 66409
2 glaxo-spero13dex2_1116.htm EX-2 25469
  Complete submission text file 0000903423-17-000691.txt   93532
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Subject) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90168 | Film No.: 171208669
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1